Amarin Seeks ITC Action Against Products 'Cloaked' As Dietary Supplements
This article was originally published in The Pink Sheet
Executive Summary
Seeking to protect its competitive interests, Vascepa marketer asks the US International Trade Commission to investigate importation and sale of synthetically produced omega-3 products by 18 companies; complaint asserts the products at issue are unapproved new drugs that are illegally being marketed as dietary supplements.